Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

P Kumar, S Saini, BS Prabhakar - Seminars in cancer biology, 2020 - Elsevier
Regulatory T-cells (Tregs) can facilitate immune evasion by tumor cells by dampening anti-
tumor immunity. Reduced Teff/Treg ratio and enhanced Treg functional activity have been …
被引用次数：100 相关文章

[引用][C] Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

P Kumar, S Saini, BS Prabhakar - Seminars in Cancer Biology, 2020 - cir.nii.ac.jp
Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events
due to loss of Treg homeostasis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ …

Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

P Kumar, S Saini, BS Prabhakar - Seminars in cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Regulatory T-cells (Tregs) can facilitate immune evasion by tumor cells by dampening anti-
tumor immunity. Reduced Teff/Treg ratio and enhanced Treg functional activity have been …

Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.

P Kumar, S Saini, BS Prabhakar - Seminars in Cancer Biology, 2019 - europepmc.org
Regulatory T-cells (Tregs) can facilitate immune evasion by tumor cells by dampening anti-
tumor immunity. Reduced Teff/Treg ratio and enhanced Treg functional activity have been …